Throughout the last three months, 17 analysts have evaluated Kimberly-Clark KMB, offering a diverse set of opinions from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 3 | 10 | 2 | 1 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 1 | 0 | 6 | 2 | 1 |
| 3M Ago | 0 | 2 | 4 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $137.18, a high estimate of $165.00, and a low estimate of $115.00. This current average reflects an increase of 6.96% from the previous average price target of $128.25.
Understanding Analyst Ratings: A Comprehensive Breakdown
A clear picture of Kimberly-Clark's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Nik Modi | RBC Capital | Raises | Outperform | $165.00 | $126.00 |
| Lauren Lieberman | Barclays | Raises | Equal-Weight | $136.00 | $132.00 |
| Filippo Falorni | Citigroup | Raises | Sell | $125.00 | $111.00 |
| Anna Lizzul | B of A Securities | Raises | Underperform | $115.00 | $110.00 |
| Nik Modi | RBC Capital | Raises | Sector Perform | $126.00 | $123.00 |
| Alejandro Zamacona | HSBC | Raises | Hold | $150.00 | $146.00 |
| Peter Grom | UBS | Raises | Neutral | $138.00 | $135.00 |
| Andrea Teixeira | JP Morgan | Raises | Underweight | $123.00 | $115.00 |
| Chris Carey | Wells Fargo | Raises | Equal-Weight | $136.00 | $131.00 |
| Jason English | Goldman Sachs | Raises | Buy | $152.00 | $135.00 |
| Lauren Lieberman | Barclays | Raises | Equal-Weight | $132.00 | $124.00 |
| Steve Powers | Deutsche Bank | Raises | Hold | $132.00 | $127.00 |
| Korinne Wolfmeyer | Piper Sandler | Raises | Overweight | $152.00 | $145.00 |
| Nik Modi | RBC Capital | Maintains | Sector Perform | $123.00 | - |
| Chris Carey | Wells Fargo | Raises | Equal-Weight | $131.00 | $125.00 |
| Javier Escalante | Evercore ISI Group | Raises | Outperform | $150.00 | $133.00 |
| Alejandro Zamacona | HSBC | Raises | Hold | $146.00 | $134.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Kimberly-Clark. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Kimberly-Clark compared to the broader market.
- Price Targets: Analysts predict movements in price targets, offering estimates for Kimberly-Clark's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.
Capture valuable insights into Kimberly-Clark's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Kimberly-Clark analyst ratings.
Discovering Kimberly-Clark: A Closer Look
With more than half of sales from personal care and another third from consumer tissue products, Kimberly-Clark sits as a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, Scott, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest predominantly concentrated in Asia and Latin America.
Breaking Down Kimberly-Clark's Financial Performance
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Challenges: Kimberly-Clark's revenue growth over 3 months faced difficulties. As of 31 March, 2024, the company experienced a decline of approximately -0.89%. This indicates a decrease in top-line earnings. When compared to others in the Consumer Staples sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Kimberly-Clark's net margin is impressive, surpassing industry averages. With a net margin of 12.57%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Kimberly-Clark's ROE stands out, surpassing industry averages. With an impressive ROE of 66.05%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 3.76%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 7.63.
Understanding the Relevance of Analyst Ratings
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
